Unknown

Dataset Information

Neutralization of CD40 ligand costimulation promotes bone formation and accretion of vertebral bone mass in mice.


ABSTRACT:

Objective

Immunosuppressive biologics are used in the management of RA and additional immunomodulators are under investigation including modulators of the CD40/CD40 ligand (CD40L) costimulation pathway. Tampering with immune function can have unanticipated skeletal consequences due to disruption of the immuno-skeletal interface, a nexus of shared cells and cytokine effectors serving discrete functions in both immune and skeletal systems. In this study, we examined the effect of MR1, a CD40L neutralizing antibody, on physiological bone remodelling in healthy mice.

Methods

Female C57BL6 mice were treated with MR1 and BMD was quantified by dual energy X-ray absorptiometry and indices of trabecular bone structure were quantified by micro-CT. Serum biochemical markers were used t

SUBMITTER: Roser-Page S 

PROVIDER: S-EPMC5965091 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature